PerCP/Cyanine5.5 anti-mouse CD3 Antibody
- 产品名称:
- PerCP/Cyanine5.5 anti-mouse CD3 Antibody
- 产品类别:
- 抗体
- 产品编号:
- 100217
- 产品应用:
- 100217
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- γδTCR-positive T-T hybridoma D1
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.
- Application Notes
Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.
- Additional Product Notes
- BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
- Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
- Product Citations
-
- Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
- Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
- Chen Y, et al. 2020. Virol Sin. . PubMed
- Abraham A, et al. 2019. J Clin Invest. 130:2685. PubMed
- Li SX, et al. 2019. PLoS Pathog. 15:e1007611. PubMed
- Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
- Marchelletta RR, et al. 2021. J Clin Invest. 131:. PubMed
- McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
- Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
- Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
- Ye Y, et al. 2022. Nat Commun. 13:6458. PubMed
- Li X, et al. 2022. Nat Commun. 13:2794. PubMed
- Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
- Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
- Pessoa Rodrigues C, et al. 2021. Sci Adv. 7:. PubMed
- Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
- Eastman A, et al. 2016. J Immunol . 194: 5999-6010. PubMed
- Molofsky A, et al. 2013. J Exp Med. 210:535. PubMed
- Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
- Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
- Chen J, et al. 2022. J Nanobiotechnology. 20:283. PubMed
- Achmus L, et al. 2020. Front Neurol. 11:577971. PubMed
- Burrack KS et al. 2018. Immunity. 48(4):760-772 . PubMed
- Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
- Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
- Yang F, et al. 2020. Cancer Res. 80:3677. PubMed
- Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
- Jin Q, et al. 2022. Drug Des Devel Ther. 16:3297. PubMed
- Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
- Zirngibl F, et al. 2021. J Immunother Cancer. 9:. PubMed
- Yang K, et al. 2022. J Clin Invest. 132:. PubMed
- Wilson AS, et al. 2022. Nat Commun. 13:528. PubMed
- Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
- Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
- Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
- Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
- Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
- Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
- Soutto M, et al. 2017. J Cancer. 8:2424. PubMed
- Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
- Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
- Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
- Vidy A, et al. 2016. PLoS One. 11:e0165361. PubMed
- Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
- Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
- Kennedy EM, et al. 2022. Nat Commun. 13:5907. PubMed
- Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
- Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
- Fu Z, et al. 2021. Cell Res. 31:631. PubMed
- Colombo M, et al. 2022. iScience. 25:105042. PubMed
- Chatterjee D, et al. 2021. Cell Reports. 35(2):108996. PubMed
- Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
- Tian Y, et al. 2016. J Immunol. 197: 1308 - 1321. PubMed
- Ren Y, et al. 2015. Sci Rep. 5: 18099. PubMed
- Andrade ACDSP, et al. 2021. J Virol. 95:e0127621. PubMed
- Shafiei-Jahani P, et al. 2021. Nat Commun. 12:2526. PubMed
- Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
- Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
- Agarwal P, et al. 2019. Cell Stem Cell. 24:769. PubMed
- Niderla-Bielinska J, et al. 2021. Int J Mol Sci. :22. PubMed
- Qadir AS, et al. 2021. iScience. 24:103348. PubMed
- Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
- Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
- Bennett FC, et al. 2018. Neuron. 98:1170. PubMed
- Shehata L, et al. 2019. Cell Rep. 28:3300. PubMed
- Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
- Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
- Laubreton D, et al. 2020. Viruses. 12:00. PubMed
- Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
- Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
- Reda M, et al. 2022. Nat Commun. 13:4261. PubMed
- Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
- Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
- Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
- Knox T, et al. 2019. Sci Rep. 9:6136. PubMed
- Theurich S et al. 2017. Cell metabolism. 26(1):171-184 . PubMed
- Jee JJ, et al. 2022. Nat Commun. 13:18. PubMed
- Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
- T?htinen S, et al. 2022. Nat Immunol. 23:532. PubMed
- Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
- Jiang Y, et al. 2015. MBio. 6: e01426-15. PubMed
- Sun Y, et al. 2022. iScience. 25:104846. PubMed
- Agarwal P, et al. 2021. Cell Reports. 36(2):109386. PubMed
- Konishi Y, et al. 2018. iScience. 10:98. PubMed
- Lai NY, et al. 2020. Cell. 180:33:00. PubMed
- Chirivi RGS, et al. 2020. Cell Mol Immunol. . PubMed
- Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
- Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
- Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
- Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
- RRID
- AB_1595597 (BioLegend Cat. No. 100217) AB_1595492 (BioLegend Cat. No. 100218)
- Structure
- Ig superfamily, CD3/TCR, 20 kD
- Distribution
-
Thymocytes (differentiation dependent), mature T cells, NK-T cells
- Function
- Antigen recognition, TCR signal transduction, T cell activation
- Ligand/Receptor
- Peptide antigen/MHC-complex
- Antigen References
-
1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.
- Gene ID
- 12502 View all products for this Gene ID
- UniProt
- View information about CD3 on UniProt.org